Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB 72 | Human | skin | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB-72 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt et al., Mol. Biotechnol., Mol Biotechnol, 2013, 53:80-89 | |||
SKMEL-23 |
Human skin malignant metastatic melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-23 |
Human skin malignant metastatic melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-224 |
Human skin malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-224 |
Human skin malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Int. J. of Pharmaceutics, 2016, 510: 30-41; doi.org/10.1016/j.ijpharm.2016.06.026 | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | |
SKBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | H.-K. Lee, PhD Thesis, 2015, Seoul National University | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | A. M. Scherbakov et al., Acta Naturae, 2015, 7(3): 133-1309 | Link | ||
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | A. M. Tamaddona et al., Iranian J. of Pharm. Sci., 2011, 11: 7(2): 79-87 | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | DOTAP | publication | M. M. M. Enriquez ez al., PLoSONE13(11):e0206818, doi.org/10.1371/journal.pone.0206818 | Link | ||
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | C. Cava et al., Theranostics, 2020, 10(1): 50-61. doi: 10.7150/thno.36274 | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Data in Brief, 2016, 8:1018-1023; doi.org/10.1016/j.dib.2016.06.064 | Link | |
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | C. Cava et al., Theranostics, 2020, 10(1): 50-61, doi: 10.7150/thno.36274 | Link | ||
SK-UT-1 |
Human uterus mesodermal tumor cell line | ATCC HTB-114 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
SK-N-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | |
SK-N-MC |
Human neuroepithelioma cell line | ATCC HTB-10 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | A. Kaiser et al., Cell. and Mol. Life Sciences, 2019, doi.org/10.1007/s00018-019-03432-7 | Link | ||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Bertoni et al., J. Biol. Chem., 2011, 286 (6): 4727–4741, DOI 10.1074/jbc.M110.156521 | Link | |
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | ||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | O. Baron et al., J. Biol. Chem, 2012, doi: 10.1074/jbc.M112.347831 | Link | ||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | ||
SK-MEL-3 |
Human skin malignant metastatic melanoma cell line | ATCC HTB-69 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 |